首页 | 本学科首页   官方微博 | 高级检索  
检索        

反相高效液相串联质谱检测法测定人血浆中阿立哌唑的浓度及临床应用
引用本文:温预关,廖日房,王西林,曾转萍,王广发,张明.反相高效液相串联质谱检测法测定人血浆中阿立哌唑的浓度及临床应用[J].中国药学杂志,2009,44(4):303-305.
作者姓名:温预关  廖日房  王西林  曾转萍  王广发  张明
作者单位:1.广州市脑科医院国家药品临床研究基地 广州 510370;2.中山大学第二附属医院药剂科 广州 510120;3.广东药学院流行病学教研室 广州 510224
基金项目:广东省自然科学研究基金资助项目(8151037001000001);广东省医院药学研究基金资助项目(200714,2008B001);广东省社会发展领域科技计划项目(53060);广州市医药卫生研究基金资助项目(2007-YB-106)
摘    要: 目的建立测定人血浆中阿立哌唑浓度的反相高效液相串联质谱电喷雾检测法(LC-ESI-MS/MS)。方法以迪马C18反相柱(4.6mm×150mm,5μm)为色谱柱,流动相为甲醇-5mmol·L-1甲酸铵(90∶10),流速为1mL·min-1,柱温:25℃,以醋酸乙酯-二氯甲烷(4∶1)为提取剂。样品经电喷雾离子源正离子化后,通过三重四级杆串联质谱仪,采用选择反应监测(SRM)对阿立哌唑(m/z 448.3→285.0)和内标替米沙坦(m/z 515.3→497.3)进行测定。并用此法测定30例患者稳态血药浓度。结果阿立哌唑的高(400μg·L-1)、中(125μg·L-1)、低(10μg·L-1)3个质量浓度的平均回收率分别为94.27%、102.58%和97.97%,日内(n=5)、日间(n=3)RSD均小于15%;分析方法的最低定量限为1μg·L-1。线性范围为:5~500μg·L-1,回归方程为F=0.5469ρ+0.0714,r=0.999(n=7)。结论该方法灵敏、准确、简单、快速,可用于临床血浓监测和药动学研究。

关 键 词:阿立哌唑  血药浓度  反相高效液相串联质谱电喷雾法
收稿时间:2008-02-07;

Study on Rapid Determination of Aripiprazole in Plasma by LC-ESI-MS/MS and Its Clinical Application
WEN Yu-guan,LIAO Ri-fang,WANG Xi-ling,ZENG Zhuan-ping,WANG Guang-fa,ZHANG Ming.Study on Rapid Determination of Aripiprazole in Plasma by LC-ESI-MS/MS and Its Clinical Application[J].Chinese Pharmaceutical Journal,2009,44(4):303-305.
Authors:WEN Yu-guan  LIAO Ri-fang  WANG Xi-ling  ZENG Zhuan-ping  WANG Guang-fa  ZHANG Ming
Institution:1. Department of Clinical Pharmacology, Guangzhou Brain Hospital, Guangzhou 510370,China;2. Department of Pharmacy, Second Affiliated Hospital of Sun Yat-sen University , Guangzhou 510120, China;3. Department of Epidemiology, Guangdong Pharmacy University, Guangzhou 510224, China
Abstract:OBJECTIVE To develop a LC-ESI-MS/MS method for aripiprazole assay in plasma. METHODS Aripiprazole was extracted with ethyl acetate- dichiloromethane (4∶1). The residues were separated on a Dikma diamonsilTM C18 column (4.6 mm×150 mm,5 μm) with the mobile phase consisting of methanol:water with 5 mmol·L-1 ammonium formate (90∶10). A agilent 6410 triple quad mass spectrometer system equipped with an electrospray ionization ion-trap source was used as the detector and operated in the positive ion mode. Selected reaction monitoring(SRM) using the precursor to product ion combinations of m/z 448.3→285.0 and m/z515.3→497.3 was performed to detect aripiprazole and the internal standard, respectively. The method was used to evaluate clinical application for 30 patients after multiple oral doses aripiprazole tablets. RESULTS The average recoveries for aripiprazole were 94.27%, 102.58% and 97.97%,respectively. The within-day (n=5) and between-day (n=3) precision of variation were less than 15%. The calibration curves for aripiprazole had good linearity , (r= 0.999,n=7) over the range of 5-500 μg·L-1. The limits of quantitation for aripiprazole was 1 μg·L-1. CONCLUSION The method provides a sensitive, accurate, precise and reliable analytical procedure for clinical monitoring of aripiprazole plasma and its phamacokinetic studies.
Keywords:aripiprazole  plasma concentration  LC-ESI-MS/MS
点击此处可从《中国药学杂志》浏览原始摘要信息
点击此处可从《中国药学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号